Xinrui Yuan

1.1k citations
40 papers · 727 indexed · h-index 15
Topics
Medical Image Segmentation Techniques (4 papers)Ubiquitin and proteasome pathways (3 papers)IL-33, ST2, and ILC Pathways (3 papers)
Partner nations
ChinaUnited StatesChile

In The Last Decade

Xinrui Yuan

38 papers receiving 706 citations

Peers

Xinrui Yuan
Comparison fields: 5 of 118
  • Molecular Biology 313
  • Radiology, Nuclear Medicine and Imaging 133
  • Oncology 107
  • Immunology 104
  • Organic Chemistry 68
Replace Bruna V. Jardim‐Perassi with:
Bruna V. Jardim‐Perassi Brazil
Kyle Hurth United States
Birgit Mosch Germany
Rubén W. Carón Argentina
Therese Eldh Germany
Lichun Wei China
Qing Ke China
Deniz Kahraman Germany
David Viertl Switzerland
G. Clarke Canada
Xinrui Yuan relative to Bruna V. Jardim‐Perassi Brazil Bruna V. Jardim‐Perassi's profile →
Citations per field
00.5×1.5×2.3×
Bruna V. Jardim‐Perassi · 1×
Citations per year

Countries citing papers authored by Xinrui Yuan

Since Specialization
Citations

This map shows the geographic impact of Xinrui Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinrui Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinrui Yuan more than expected).

Fields of papers citing papers by Xinrui Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinrui Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinrui Yuan. The network helps show where Xinrui Yuan may publish in the future.

Co-authorship network of co-authors of Xinrui Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Xinrui Yuan. A scholar is included among the top collaborators of Xinrui Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinrui Yuan. Xinrui Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 6
3 47
4 2
5 31
6 4
7 0
8 7
9 3
10 7
11 1
12 11
13 9
14 14
15 106
16 7
17 14
18 44
19 16
20 19

About Xinrui Yuan

Xinrui Yuan is a scholar working on Immunology, Process Chemistry and Technology and Computer Vision and Pattern Recognition, having authored 40 papers that have together received 727 indexed citations. Recurring topics across this work include Medical Image Segmentation Techniques (4 papers), Ubiquitin and proteasome pathways (3 papers) and IL-33, ST2, and ILC Pathways (3 papers). The work is most often cited by research in Health Informatics (19 citations), Otorhinolaryngology (37 citations) and Toxicology (22 citations). Xinrui Yuan has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Jinpei Zhou, Hong Bu, Chao‐Yie Yang, Huibin Zhang, Shangqing Liu, Yu Zhang, Shujun Liang, Xia Huang, Tao Zhong and Fan Tang. Their work appears in journals such as Cell, Neuron and The Journal of Physical Chemistry B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026